Omron Corp. (OTCMKTS:OMRNY – Get Free Report) was the recipient of a large increase in short interest during the month of January. As of January 30th, there was short interest totaling 16,138 shares, an increase of 56.0% from the January 15th total of 10,346 shares. Based on an average trading volume of 64,084 shares, the days-to-cover ratio is currently 0.3 days. Approximately 0.0% of the shares of the stock are short sold. Approximately 0.0% of the shares of the stock are short sold. Based on an average trading volume of 64,084 shares, the days-to-cover ratio is currently 0.3 days.
Analyst Ratings Changes
Separately, Zacks Research raised shares of Omron from a “strong sell” rating to a “hold” rating in a research note on Monday, January 19th. One analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, the company has an average rating of “Hold”.
View Our Latest Stock Report on OMRNY
Omron Trading Up 0.1%
Omron (OTCMKTS:OMRNY – Get Free Report) last announced its quarterly earnings data on Thursday, February 5th. The company reported $0.17 EPS for the quarter, missing analysts’ consensus estimates of $0.36 by ($0.19). The company had revenue of $1.41 billion for the quarter, compared to analyst estimates of $1.38 billion. Omron had a return on equity of 2.46% and a net margin of 2.80%.Omron has set its FY 2025 guidance at 0.960-0.960 EPS. Equities analysts predict that Omron will post 0.42 earnings per share for the current year.
Institutional Investors Weigh In On Omron
An institutional investor recently raised its position in Omron stock. GAMMA Investing LLC lifted its holdings in shares of Omron Corp. (OTCMKTS:OMRNY – Free Report) by 50.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,129 shares of the company’s stock after purchasing an additional 716 shares during the quarter. GAMMA Investing LLC’s holdings in Omron were worth $54,000 at the end of the most recent quarter. Institutional investors and hedge funds own 1.09% of the company’s stock.
About Omron
Omron Corporation (OTCMKTS: OMRNY) is a global leader in automation, sensing, and control technologies. The company designs, manufactures, and sells a wide range of products and solutions for industrial, healthcare and social systems applications. Its core business segments include industrial automation—featuring programmable logic controllers, sensors, relays, servo motors and temperature controllers—and healthcare products such as blood pressure monitors, digital thermometers and nebulizers.
Founded in 1933 by Kazuma Tateishi in Kyoto, Japan, Omron began with the development of the first Japanese automatic timer.
See Also
- Five stocks we like better than Omron
- Think You Missed Silver? You’re Wrong. Here’s Why.
- Nvidia CEO Issues Bold Tesla Call
- America’s 1776 happening again
- NEW LAW: Congress Approves Setup For Digital Dollar?
- They just tried to kill gold
Receive News & Ratings for Omron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omron and related companies with MarketBeat.com's FREE daily email newsletter.
